Treatment group:Orelabrutinib

2 trials

Sponsors

Xinqiao Hospital of Army Medical University, The First Affiliated Hospital, College of Medicine, Zhejiang University

Conditions

Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPrimary central nervous system diffuse large B-cell lymphoma

Phase 4

Clinical application of orelabrutinib targeted therapy in induction and maintenance therapy of primary central nervous system diffuse large B-cell lymphoma

RecruitingChiCTR2100052815

Xinqiao Hospital of Army Medical UniversityPrimary central nervous system diffuse large B-cell lymphoma

Start: 2021-11-01Updated: 2022-08-16

Unknown Phase

Exploration of Determinants of Treatment Response to Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study

Active, not recruitingChiCTR2400094533

The First Affiliated Hospital, College of Medicine, Zhejiang UniversityChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Start: 2024-12-24Updated: 2025-01-06